LambdaTest partners with testRigor to empower businesses to do end-to-end automation testing on one integrated platform 18-07-2023, 22:30

Junshi Biosciences Announces Positive Opinion from the European Medicines Agency’s CHMP For Toripalimab 26-07-2024, 21:46

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00